BlackRock’s Bio-Path Holdings Inc BPTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,381
Closed -$2.76K 5589
2024
Q4
$2.76K Hold
2,381
﹤0.01% 5267
2024
Q3
$2.17K Hold
2,381
﹤0.01% 5099
2024
Q2
$4.76K Hold
2,381
﹤0.01% 5130
2024
Q1
$9.81K Sell
2,381
-354
-13% -$2.67K ﹤0.01% 5089
2023
Q4
$25.3K Buy
2,735
+312
+13% +$3.28K ﹤0.01% 5058
2023
Q3
$17.9K Hold
2,423
﹤0.01% 5156
2023
Q2
$86.3K Hold
2,423
﹤0.01% 4963
2023
Q1
$67.4K Hold
2,423
﹤0.01% 5057
2022
Q4
$73.2K Hold
2,423
﹤0.01% 5129
2022
Q3
$155K Hold
2,423
﹤0.01% 5045
2022
Q2
$188K Sell
2,423
-837
-26% -$56.6K ﹤0.01% 5050
2022
Q1
$250K Sell
3,260
-41
-1% -$2.99K ﹤0.01% 5052
2021
Q4
$249K Sell
3,301
-86
-3% -$7.96K ﹤0.01% 5060
2021
Q3
$348K Sell
3,387
-21
-0.6% -$2.52K ﹤0.01% 4854
2021
Q2
$454K Buy
3,408
+412
+14% +$50.8K ﹤0.01% 4717
2021
Q1
$421K Hold
2,996
﹤0.01% 4632
2020
Q4
$210K Hold
2,996
﹤0.01% 4475
2020
Q3
$254K Hold
2,996
﹤0.01% 4367
2020
Q2
$302K Sell
2,996
-477
-14% -$49.5K ﹤0.01% 4298
2020
Q1
$313K Buy
3,473
+205
+6% +$24.3K ﹤0.01% 4150
2019
Q4
$522K Buy
3,268
+943
+41% +$177K ﹤0.01% 4153
2019
Q3
$442K Sell
2,325
-19
-0.8% -$4.72K ﹤0.01% 4199
2019
Q2
$628K Buy
2,344
+349
+17% +$111K ﹤0.01% 4137
2019
Q1
$813K Buy
1,995
+1,976
+10,400% +$363K ﹤0.01% 3977
2018
Q4
$1K Buy
19
+2
+12% +$343 ﹤0.01% 4927
2018
Q3
$4K Hold
17
﹤0.01% 4840
2018
Q2
$10K Buy
17
+1
+6% +$696 ﹤0.01% 4752
2018
Q1
$13K Sell
16
-4
-20% -$3.12K ﹤0.01% 4623
2017
Q4
$16K Buy
20
+1
+5% +$1.29K ﹤0.01% 4597
2017
Q3
$28K Buy
19
+1
+6% +$1.37K ﹤0.01% 4552
2017
Q2
$28K Sell
18
-947
-98% -$1.99M ﹤0.01% 4613
2017
Q1
$3.19M Buy
965
+964
+96,400% +$3.5M ﹤0.01% 3521
2016
Q4
$4K Hold
1
﹤0.01% 3559
2016
Q3
$4K Hold
1
﹤0.01% 3532
2016
Q2
$6K Buy
+1
New +$10.1K ﹤0.01% 3499
2015
Q2
Hold
0
-$3K 3285
2015
Q1
Hold
0
3107
2014
Q4
Hold
0
3077
2014
Q3
Hold
0
3130
2014
Q2
Hold
0
3082

Other funds holding BPTH

BlackRock's BPTH Position: Q1 2025 in Review

BlackRock sold out of Bio-Path Holdings Inc (BPTH) in Q1 2025, closing a stake of 2,381 shares — an estimated $2.76K sold.

BlackRock first reported a position in BPTH in Q2 2016 and held it in 35 quarters. The position peaked at $3.19M in Q1 2017. 2 funds tracked by Wall St. Rank hold BPTH as of Q1 2025.

  • BlackRock reported no remaining Bio-Path Holdings Inc position as of Q1 2025 after selling out during the quarter.
  • BlackRock sold 2,381 Bio-Path Holdings Inc shares in Q1 2025, an estimated $2.76K.
  • BlackRock first reported a position in Bio-Path Holdings Inc in Q2 2016 and held it in 35 quarters.
  • BlackRock's Bio-Path Holdings Inc position peaked at $3.19M in Q1 2017.
  • 2 funds tracked by Wall St. Rank held Bio-Path Holdings Inc as of Q1 2025.

Based on BlackRock's 13F filing for Q1 2025, filed 2 May 2025.